Literature DB >> 22684721

Topoisomerase assays.

John L Nitiss1, Eroica Soans, Anna Rogojina, Aman Seth, Margarita Mishina.   

Abstract

Topoisomerases are nuclear enzymes that play essential roles in DNA replication, transcription, chromosome segregation, and recombination. All cells have two major forms of topoisomerases: type I enzymes, which make single-stranded cuts in DNA, and type II enzymes, which cut and pass double-stranded DNA. DNA topoisomerases are important targets of approved and experimental anti-cancer agents. The protocols described in this unit are for assays used to assess new chemical entities for their ability to inhibit both forms of DNA topoisomerase. Included are an in vitro assay for topoisomerase I activity based on relaxation of supercoiled DNA, and an assay for topoisomerase II based on the decatenation of double-stranded DNA. The preparation of mammalian cell extracts for assaying topoisomerase activity is described, along with a protocol for an ICE assay to examine topoisomerase covalent complexes in vivo, and an assay for measuring DNA cleavage in vitro.
© 2012 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684721      PMCID: PMC3397423          DOI: 10.1002/0471141755.ph0303s57

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  53 in total

1.  A protease pathway for the repair of topoisomerase II-DNA covalent complexes.

Authors:  Ailing Zhang; Yi Lisa Lyu; Chao-Po Lin; Nai Zhou; Anna M Azarova; Laurence M Wood; Leroy F Liu
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

Review 2.  Detection and quantitation of radiolabeled proteins and DNA in gels and blots.

Authors:  D Voytas; N Ke
Journal:  Curr Protoc Mol Biol       Date:  2001-05

Review 3.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 4.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

5.  Immunoblotting and immunodetection.

Authors:  Sean Gallagher; Scott E Winston; Steven A Fuller; John G R Hurrell
Journal:  Curr Protoc Mol Biol       Date:  2008-07

6.  DNA cleavage assay for the identification of topoisomerase I inhibitors.

Authors:  Thomas S Dexheimer; Yves Pommier
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 7.  DNA topoisomerases: harnessing and constraining energy to govern chromosome topology.

Authors:  Allyn J Schoeffler; James M Berger
Journal:  Q Rev Biophys       Date:  2008-02       Impact factor: 5.318

8.  Denaturing polyacrylamide gel electrophoresis.

Authors:  L M Albright; B E Slatko
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2001-05

9.  Biochemical and biophysical analyses of recombinant forms of human topoisomerase I.

Authors:  L Stewart; G C Ireton; L H Parker; K R Madden; J J Champoux
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

10.  Agarose gel electrophoresis.

Authors:  D Voytas
Journal:  Curr Protoc Mol Biol       Date:  2001-05
View more
  41 in total

1.  Mechanism of heat stress-induced cellular senescence elucidates the exclusive vulnerability of early S-phase cells to mild genotoxic stress.

Authors:  Artem K Velichko; Nadezhda V Petrova; Sergey V Razin; Omar L Kantidze
Journal:  Nucleic Acids Res       Date:  2015-06-01       Impact factor: 16.971

2.  ZATT (ZNF451)-mediated resolution of topoisomerase 2 DNA-protein cross-links.

Authors:  Matthew J Schellenberg; Jenna Ariel Lieberman; Andrés Herrero-Ruiz; Logan R Butler; Jason G Williams; Ana M Muñoz-Cabello; Geoffrey A Mueller; Robert E London; Felipe Cortés-Ledesma; R Scott Williams
Journal:  Science       Date:  2017-09-14       Impact factor: 47.728

3.  Trapped topoisomerase II initiates formation of de novo duplications via the nonhomologous end-joining pathway in yeast.

Authors:  Nicole Stantial; Anna Rogojina; Matthew Gilbertson; Yilun Sun; Hannah Miles; Samantha Shaltz; James Berger; Karin C Nitiss; Sue Jinks-Robertson; John L Nitiss
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-12       Impact factor: 11.205

4.  RECQ5-dependent SUMOylation of DNA topoisomerase I prevents transcription-associated genome instability.

Authors:  Min Li; Subhash Pokharel; Jiin-Tarng Wang; Xiaohua Xu; Yilun Liu
Journal:  Nat Commun       Date:  2015-04-08       Impact factor: 14.919

5.  Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2).

Authors:  Le-Mao Yu; Zhu Hu; Yu Chen; Azhar Ravji; Sophia Lopez; Caroline B Plescia; Qian Yu; Hui Yang; Monica Abdelmalak; Sourav Saha; Keli Agama; Evgeny Kiselev; Christophe Marchand; Yves Pommier; Lin-Kun An
Journal:  Eur J Med Chem       Date:  2018-04-12       Impact factor: 6.514

6.  Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes.

Authors:  Ram Madabhushi; Fan Gao; Andreas R Pfenning; Ling Pan; Satoko Yamakawa; Jinsoo Seo; Richard Rueda; Trongha X Phan; Hidekuni Yamakawa; Ping-Chieh Pao; Ryan T Stott; Elizabeta Gjoneska; Alexi Nott; Sukhee Cho; Manolis Kellis; Li-Huei Tsai
Journal:  Cell       Date:  2015-06-04       Impact factor: 41.582

7.  The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and TOP2.

Authors:  Laetitia Marzi; Yilun Sun; Shar-Yin N Huang; Amy James; Simone Difilippantonio; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2020-05-19       Impact factor: 6.261

8.  The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning.

Authors:  Peter M Bruno; Mengrou Lu; Kady A Dennis; Haider Inam; Connor J Moore; John Sheehe; Stephen J Elledge; Michael T Hemann; Justin R Pritchard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-10       Impact factor: 11.205

9.  Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity.

Authors:  Andres Canela; Yaakov Maman; Shar-Yin N Huang; Gordana Wutz; Wen Tang; Guido Zagnoli-Vieira; Elsa Callen; Nancy Wong; Amanda Day; Jan-Michael Peters; Keith W Caldecott; Yves Pommier; André Nussenzweig
Journal:  Mol Cell       Date:  2019-06-12       Impact factor: 17.970

10.  The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them.

Authors:  Martyn T Smith; Kathryn Z Guyton; Nicole Kleinstreuer; Alexandre Borrel; Andres Cardenas; Weihsueh A Chiu; Dean W Felsher; Catherine F Gibbons; William H Goodson; Keith A Houck; Agnes B Kane; Michele A La Merrill; Herve Lebrec; Leroy Lowe; Cliona M McHale; Sheroy Minocherhomji; Linda Rieswijk; Martha S Sandy; Hideko Sone; Amy Wang; Luoping Zhang; Lauren Zeise; Mark Fielden
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-03-09       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.